(Q39007287)

8 September 2017

title

S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer (English)

1 reference

8 September 2017

0 references

Jianli Zhang

1

1 reference

8 September 2017

Kejun Zhang

series ordinal

2

1 reference

8 September 2017

Xiuli Jiang

series ordinal

3

1 reference

8 September 2017

Jian Zhang

series ordinal

4

1 reference

8 September 2017

publication date

5 April 2014

1 reference

Digestive Diseases and Sciences

8 September 2017

published in

1 reference

8 September 2017

volume

59

1 reference

8 September 2017

issue

9

1 reference

8 September 2017

page(s)

2136-2144

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-014-3137-z

8 September 2017

exact match

0 references

cites work

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Chemotherapy options for gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

S100A6 - new facts and features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Upregulated expression of S100A6 in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

S100A6 expression and function in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3137-Z

Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24705642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24705642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Knockdown of PLA2G2A sensitizes gastric cancer cells to 5-FU in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24705642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10620-014-3137-Z

1 reference

8 September 2017

1 reference